{"Background": [108, 669, 0], "Methods": [670, 1003, 0, 9198, 20010, 1], "Results": [1004, 2053, 0, 20011, 30291, 1], "Conclusions": [2054, 2596, 0], "What is already known on this topic": [2634, 2959, 0, 2597, 3878, 1], "What this study adds": [2960, 3256, 0], "How this study might affect research, practice or policy": [3257, 3878, 0], "Introduction": [3879, 9197, 0], "Study design and sample collection": [9207, 12460, 0], "Time points": [12461, 12792, 0], "Sample collection": [12793, 13500, 0], "Antibody response": [13501, 15525, 0], "T cell responses": [15526, 18538, 0], "Data analysis": [18539, 19611, 0], "Statistical analysis": [19612, 20010, 0], "Patient demographics and cohort": [20020, 21444, 0], "Antibody responses to RBD and Spike": [21445, 26472, 0], "T cell responses to WT and B.1.617.2 variants": [26473, 28792, 0], "Adrenal crisis and irAEs after vaccination": [28793, 30291, 0], "Discussion": [30292, 41091, 0]}